Use of Antifungals and Outcomes Among Inpatients at Risk of Invasive Aspergillosis or Mucormycosis in the USA: A Retrospective Cohort Study

INTRODUCTION: Prophylaxis and treatment of invasive aspergillosis (IA) and mucormycosis (IM) within a real-world US inpatient setting is undocumented since the introduction of isavuconazole. This retrospective medical record review aimed to describe characteristics, triazole use, and outcomes among...

Descripción completa

Detalles Bibliográficos
Autores principales: Stull, Katherine, Esterberg, Elizabeth, Ajmera, Mayank, Candrilli, Sean, Kitt, Therese M., Spalding, James R., Patel, Vanessa Perez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856226/
https://www.ncbi.nlm.nih.gov/pubmed/31598932
http://dx.doi.org/10.1007/s40121-019-00267-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856226/
https://www.ncbi.nlm.nih.gov/pubmed/31598932
http://dx.doi.org/10.1007/s40121-019-00267-4

Ejemplares similares